|
1
|
Mamelak AN and Jacoby DB: Targeted
delivery of antitumoral therapy to glioma and other malignancies
with synthetic chlorotoxin (TM-601). Expert Opin Drug Deliv.
4:175–186. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Goodenberger ML and Jenkins RB: Genetics
of adult glioma. Cancer Genet. 205:613–621. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Osoba D, Brada M, Prados MD and Yung WK:
Effect of disease burden on health-related quality of life in
patients with malignant gliomas. Neuro Oncol. 2:221–228. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Tym R: Piloid gliomas of the anterior
optic pathways. Br J Surg. 49:322–331. 1961. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gutin PH, Phillips TL, Wara WM, Leibel SA,
Hosobuchi Y, Levin VA, Weaver KA and Lamb S: Brachytherapy of
recurrent malignant brain tumors with removable high-activity
iodine-125 sources. J Neurosurg. 60:61–68. 1984. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Yung WK, Kyritsis AP, Gleason MJ and Levin
VA: Treatment of recurrent malignant gliomas with high-dose
13-cis-retinoic acid. Clin Cancer Res. 2:1931–1935.
1996.PubMed/NCBI
|
|
7
|
Furnari FB, Fenton T, Bachoo RM, Mukasa A,
Stommel JM, Stegh A, Hahn WC, Ligon KL, Louis DN, Brennan C, et al:
Malignant astrocytic glioma: Genetics, biology, and paths to
treatment. Genes Dev. 21:2683–2710. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Herman JG, Latif F, Weng Y, Lerman MI,
Zbar B, Liu S, Samid D, Duan DS, Gnarra JR, Linehan WM, et al:
Silencing of the VHL tumor-suppressor gene by DNA methylation in
renal carcinoma. Proc Natl Acad Sci USA. 91:9700–9704. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Antequera F and Bird A: Number of CpG
islands and genes in human and mouse. Proc Natl Acad Sci USA.
90:11995–11999. 1993. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Jones PA and Buckley JD: The role of DNA
methylation in cancer. Adv Cancer Res. 54:1–23. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Costello JF, Berger MS, Huang HS and
Cavenee WK: Silencing of p16/CDKN2 expression in human gliomas by
methylation and chromatin condensation. Cancer Res. 56:2405–2410.
1996.PubMed/NCBI
|
|
12
|
Skiriute D, Vaitkiene P, Saferis V,
Asmoniene V, Skauminas K, Deltuva VP and Tamasauskas A: MGMT,
GATA6, CD81, DR4 and CASP8 gene promoter methylation in
glioblastoma. BMC Cancer. 12:2182012. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Spiegl-Kreinecker S, Pirker C, Filipits M,
Lötsch D, Buchroithner J, Pichler J, Silye R, Weis S, Micksche M,
Fischer J and Berger W: O6-Methylguanine DNA methyltransferase
protein expression in tumor cells predicts outcome of temozolomide
therapy in glioblastoma patients. Neuro Oncol. 12:28–36. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chen HY, Shao CJ, Chen FR, Kwan AL and
Chen ZP: Role of ERCC1 promoter hypermethylation in drug resistance
to cisplatin in human gliomas. Int J Cancer. 126:1944–1954.
2010.PubMed/NCBI
|
|
15
|
Barrett T, Troup DB, Wilhite SE, Ledoux P,
Evangelista C, Kim IF, Tomashevsky M, Marshall KA, Phillippy KH,
Sherman PM, et al: NCBI GEO: Archive for functional genomics data
sets-10 years on. Nucleic Acids Res. 39:(Database Issue).
D1005–D1010. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Crookston NL and Finley AO: Yaimpute: An r
package for knn imputation. J Statistical Software. 23:1–16. 2008.
View Article : Google Scholar
|
|
17
|
Bolstad BM and Bolstad MBM: Package
‘preprocessCore’. 2013.
|
|
18
|
Smyth GK: Limma: Linear models for
microarray dataStatistics for Biology and Health: Bioinformatics
and Computational Biology Solutions using R and Bioconductor.
Gentleman R, Carey V, Huber W, Irizarry R and Dudoit S: Springer;
New York: pp. 397–420. 2005, View Article : Google Scholar
|
|
19
|
Karolchik D, Barber GP, Casper J, Clawson
H, Cline MS, Diekhans M, Dreszer TR, Fujita PA, Guruvadoo L,
Haeussler M, et al: The UCSC genome browser database: 2014 Update.
Nucleic Acids Res. 42:(Database Issue). D764–D770. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Shannon P, Markiel A, Ozier O, Baliga NS,
Wang JT, Ramage D, Amin N, Schwikowski B and Ideker T: Cytoscape: A
software environment for integrated models of biomolecular
interaction networks. Genome Res. 13:2498–2504. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Hulsegge I, Kommadath A and Smits MA:
Globaltest and GOEAST: Two different approaches for Gene Ontology
analysis. BMC Proc. 3 Suppl 4:S102009. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Ogata H, Goto S, Sato K, Fujibuchi W, Bono
H and Kanehisa M: KEGG: Kyoto encyclopedia of genes and genomes.
Nucleic Acids Res. 27:29–34. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Dennis G Jr, Sherman BT, Hosack DA, Yang
J, Gao W, Lane HC and Lempicki RA: DAVID: Database for annotation,
visualization and integrated discovery. Genome Biol. 4:P32003.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Li C and Li MC: Package ‘iSubpathway
Miner’. 2013.
|
|
25
|
Chakravarti A, Zhai GG, Zhang M, Malhotra
R, Latham DE, Delaney MA, Robe P, Nestler U, Song Q and Loeffler J:
Survivin enhances radiation resistance in primary human
glioblastoma cells via caspase-independent mechanisms. Oncogene.
23:7494–7506. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Joo A, Shibata H, Ninomiya H, Kawasaki H,
Tashiro N and Fukumaki Y: Structure and polymorphisms of the human
metabotropic glutamate receptor type 2 gene (GRM2): Analysis of
association with schizophrenia. Mol Psychiatry. 6:186–192. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Flor PJ, Lindauer K, Püttner I, Rüegg D,
Lukic S, Knöpfel T and Kuhn R: Molecular cloning, functional
expression and pharmacological characterization of the human
metabotropic glutamate receptor type 2. Eur J Neurosci. 7:622–629.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Meldrum BS: Glutamate as a
neurotransmitter in the brain: Review of physiology and pathology.
J Nutr. 130 4S Suppl:1007S–1015S. 2000.PubMed/NCBI
|
|
29
|
Ullian EM, Christopherson KS and Barres
BA: Role for glia in synaptogenesis. Glia. 47:209–216. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bezzi P and Volterra A: A neuron-glia
signalling network in the active brain. Curr Opin Neurobiol.
11:387–394. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Giese A and Westphal M: Glioma invasion in
the central nervous system. Neurosurgery. 39:235–250. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Longo AM and Penhoet EE: Nerve growth
factor in rat glioma cells. Proceedings of the National Academy of
Sciences. 71:2347–2349. 1974. View Article : Google Scholar
|
|
33
|
Kordi-Tamandani DM, Dahmardeh N and
Torkamanzehi A: Evaluation of hypermethylation and expression
pattern of GMR2, GMR5, GMR8 and GRIA3 in patients with
schizophrenia. Gene. 515:163–166. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Arcella A, Carpinelli G, Battaglia G,
D'Onofrio M, Santoro F, Ngomba RT, Bruno V, Casolini P, Giangaspero
F and Nicoletti F: Pharmacological blockade of group II
metabotropic glutamate receptorsreduces the growth of glioma cells
in vivo. Neuro Oncol. 7:236–245. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Tilly BC, van Paridon PA, Verlaan I, Wirtz
KW, de Laat SW and Moolenaar WH: Inositol phosphate metabolism in
bradykinin-stimulated human A431 carcinoma cells. Relationship to
calcium signalling. Biochem J. 244:129–135. 1987. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lee E and Yuspa SH: Changes in inositol
phosphate metabolism are associated with terminal differentiation
and neoplasia in mouse keratinocytes. Carcinogenesis. 12:1651–1658.
1991. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Mishra J and Bhalla US: Simulations of
inositol phosphate metabolism and its interaction with
InsP3-mediated calcium release. Biophys J. 83:1298–1316. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
El-Rifai W, Moskaluk CA, Abdrabbo MK,
Harper J, Yoshida C, Riggins GJ, Frierson HF Jr and Powell SM:
Gastric cancers overexpress S100A calcium-binding proteins. Cancer
Res. 62:6823–6826. 2002.PubMed/NCBI
|
|
39
|
Kato H, Uzawa K, Onda T, Kato Y, Saito K,
Nakashima D, Ogawara K, Bukawa H, Yokoe H and Tanzawa H:
Down-regulation of 1D-myo-inositol 1,4,5-trisphosphate 3-kinase A
protein expression in oral squamous cell carcinoma. Int J Oncol.
28:873–881. 2006.PubMed/NCBI
|
|
40
|
Windhorst S, Fliegert R, Blechner C,
Möllmann K, Hosseini Z, Günther T, Eiben M, Chang L, Lin HY, Fanick
W, et al: Inositol 1,4,5-trisphosphate 3-kinase-A is a new cell
motility-promoting protein that increases the metastatic potential
of tumor cells by two functional activities. J Biol Chem.
285:5541–5554. 2010. View Article : Google Scholar : PubMed/NCBI
|
